Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
about
Periprosthetic bone density as outcome of therapeutic response.Anticytokine therapy for osteoarthritis.Preliminary results of implantation in animal model and osteoblast culture evaluation of prototypes of biomimetic multispiked connecting scaffold for noncemented stemless resurfacing hip arthroplasty endoprostheses.Biological response to prosthetic debris.Inhibiting wear particles-induced osteolysis with naringin.Aseptic loosening, not only a question of wear: a review of different theories.Progranulin suppresses titanium particle induced inflammatory osteolysis by targeting TNFα signaling.Pre-surgical radiologic identification of peri-prosthetic osteolytic lesions around TKRs: a pre-clinical investigation of diagnostic accuracy.Prevalence of periprosthetic osteolysis after total hip replacement in patients with rheumatic diseases.PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysisNovel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement.Metal ions as inflammatory initiators of osteolysis.Cellular chemotaxis induced by wear particles from joint replacementsTumor necrosis factor-alpha levels after surgical anti-infective mechanical therapy for peri-implantitis: a 12-month follow-up.Statins attenuate polymethylmethacrylate-mediated monocyte activation.
P2860
Q33965664-08688477-7C84-4743-BDCD-4553749C680BQ34452635-BE55C6DE-0F2A-4FFC-8CEE-D52A7BB82864Q34975540-5748E2ED-DB4F-45CF-8A12-486F9E855511Q35188740-9EAF8D53-B73A-4D3E-8C57-12952421DD0FQ36495023-945865E5-BAEC-4CCF-9E10-2B3F9BECDF1FQ36496869-48A927B0-C97C-49C6-94C2-FBE10B725590Q36569740-DE7F704A-DFE8-4A77-9FB5-87DE2C3F74ABQ36944361-AFBA5CFA-1636-447F-B232-6C189355DFC7Q37301140-3F289638-EF17-49F3-9813-C27AE200B7E1Q37345108-BCABB563-4574-4ECF-96AE-B94213C96FB4Q38183358-F3A5D8FD-316A-47C5-BFF4-1F6ADC140F02Q38386045-F4CEC350-7E92-44CD-8CC8-A3F079FD5324Q40832321-72DA7CFD-0ED2-41A7-B2B4-F28758535998Q46067295-8BB96A26-FEAE-422F-92FE-BF7D7450AF39Q46746313-30BC304C-EFDF-481C-83DD-07AB5052AB78
P2860
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis
@nl
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@ast
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@en
type
label
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis
@nl
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@ast
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@en
prefLabel
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis
@nl
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@ast
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@en
P2093
P2860
P921
P356
P1476
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis.
@en
P2093
E M Schwarz
R J Looney
R J O'Keefe
P2860
P2888
P304
P356
10.1186/AR81
P407
P577
2000-03-27T00:00:00Z
P5875
P6179
1008599709